Aptinyx Inc reported $-14557000 in EBITDA for its third fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Ebitda Change
Acadia Pharmaceuticals ACAD:US USD -45574000 15.21M
Acorda Therapeutics ACOR:US USD 7.96M 5.15M
Biogen BIIB:US USD 998.8M 6M
Cara Therapeutics CARA:US USD -31246000 7.46M
Daiichi Sankyo 4568:JP JPY 47.64B 28.67B
Halozyme Therapeutics HALO:US USD 83.06M 29.83M
Intra Cellular Therapies ITCI:US USD -47225000 8.23M
Marinus Pharmaceuticals MRNS:US USD -29130000 811K
Neurocrine Biosciences NBIX:US USD 107.8M 16M
Novartis NOVN:VX USD 4.5B 193M
Ultragenyx Pharmaceutical RARE:US USD -140671000 79.7M